glp 1 weight loss indication GLP-1 agonists for loss: What you need to know GLP-1: A Breakthrough in Diabetes

Manish Sahni, MD.

In real-world settings multiple factors contribute to non-persistence, including adverse effects, high cost-sharing and weight loss not meeting patients' expectations.

Literally. If youre taking a GLP-1 medication like semaglutide or tirzepatide and you feel like your digestion has slowed to a glacial pace, youre not alone

Emerging evidence suggests these agents also exert ...

Exposures Two cohorts were assembled, with the first composed of patients who started and continued on GLP-1 receptor agonists or DPP-4 inhibitors between 1 January 2007 and 31 December 2020 and the second composed of patients who started and continued on GLP-1 receptor agonists or SGLT-2 inhibitors between 1 January 1 2013 and 31 December 2020

This update comes from The Use of Medicines in the U.S